Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · Real-Time Price · USD
3.850
0.00 (0.00%)
May 9, 2025, 11:11 AM - Market open
Bionano Genomics Revenue
In the year 2024, Bionano Genomics had annual revenue of $30.78M, down -14.79%. Bionano Genomics had revenue of $8.16M in the quarter ending December 31, 2024, a decrease of -23.86%.
Revenue (ttm)
$30.78M
Revenue Growth
-14.79%
P/S Ratio
0.16
Revenue / Employee
$307,760
Employees
100
Market Cap
11.58M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Abbott Laboratories | 42.34B |
BNGO News
- 1 day ago - Bionano to Report First Quarter 2025 Financial Results and Host a Conference Call Webcast on May 14, 2025 - GlobeNewsWire
- 7 days ago - International Consortium for Optical Genome Mapping Publishes Expert Recommendations for Integration of OGM as a Standard-of-Care Cytogenetic Assay for Diagnostic Workflows in Blood Cancers - GlobeNewsWire
- 16 days ago - Bionano Announces Publication Showing OGM can Provide an Accurate and Cost-Effective Solution for Sizing Large Repeat Expansions in Constitutional Genetic Disease - GlobeNewsWire
- 4 weeks ago - Bionano Announces French Publication of an Effective Method for Analysis of Multiple Myeloma by OGM - GlobeNewsWire
- 5 weeks ago - Bionano Genomics, Inc. (BNGO) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Bionano Reports Fourth Quarter and Full-Year 2024 Results and Provides Revenue Outlook for 2025 - GlobeNewsWire
- 6 weeks ago - Study Using OGM in Neural Tube Defects Reveals Previously Unreported Variants and Candidate Genes with Potential Links to the Devastating Birth Defect - GlobeNewsWire
- 7 weeks ago - Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) 2025 Annual Meeting - GlobeNewsWire